People · Operator
Named in public records as an officer, director or promoter · active 2016–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Color Health, Inc. | — | Biotechnology | Series D+ | $300.9M | $1.2B | 2016 |
| Frontier Medicines Corp | — | Biotechnology | Series C | $122.0M | $2.5B | 2019 |
Othman Laraki at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Othman Laraki on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Hemant Taneja | 1 | 21 |
| Luke Evnin | 1 | 12 |
| Cameron Wheeler | 1 | 9 |
| Janwillem Naesens | 1 | 3 |
| Taneja Hemant | 1 | 3 |
| Elad Gil | 1 | 2 |
| Jim Winkler | 1 | 1 |
| Johannes Hermann, Ph.D. | 1 | 1 |
| Kevin Webster | 1 | 1 |
| Gregory Chow | 1 | 1 |
| Chris Varma, Ph.D. | 1 | 1 |
| Susan L. Wagner | 1 | 1 |
| Michael L. Herring | 1 | 1 |
| Hemant L. Taneja | 1 | 1 |
| Gil Elad | 1 | 1 |
| Sherwin L Chen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.